Search
for
Sort by
Research 31–60 of 1000+
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Chemotherapy and Cutaneous Drug Reactions
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Severe cutaneous adverse reactions to drugs
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- Comparative study of the chemical profile, cytotoxic activity, and molecular docking of Serenoa repens extract and a pharmaceutical product
- Investigating drug induced alopecia
- Dermatological adverse events with taxane chemotherapy
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Role of Cytotoxic T Cells in Chronic Alopecia Areata
- Cytotoxic Evaluation of Hair Relaxers and Straighteners Actives in Human-Derived Skin Cells
- TOXIC EPIDERMAL NECROLYSIS
- Cutaneous complications of chemotherapeutic agents
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Apoptosis and cutaneous biology
- Hair disorders in patients with cancer
- Acquired scalp alopecia. Part I: A review
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Male fertility and skin diseases